Name | Number of Publications
|
Most Recent Publication
|
Publications by All Authors
|
Concept Score
|
Why?
|
---|
Genetic Vectors | 66 | 2014 | 3380 | 1.740 |
Why?
|
Retroviridae | 49 | 2004 | 850 | 1.490 |
Why?
|
Gene Transfer Techniques | 26 | 2014 | 1204 | 1.430 |
Why?
|
Granulocyte-Macrophage Colony-Stimulating Factor | 26 | 2013 | 886 | 1.090 |
Why?
|
Transfection | 48 | 2009 | 5781 | 1.080 |
Why?
|
Transduction, Genetic | 21 | 2010 | 897 | 0.820 |
Why?
|
Hematopoietic Stem Cells | 27 | 2011 | 3387 | 0.820 |
Why?
|
Moloney murine leukemia virus | 18 | 2004 | 109 | 0.780 |
Why?
|
Genetic Engineering | 15 | 2007 | 933 | 0.680 |
Why?
|
RNA, Catalytic | 3 | 2007 | 53 | 0.580 |
Why?
|
Receptors, Dopamine D4 | 2 | 2014 | 170 | 0.560 |
Why?
|
Minisatellite Repeats | 2 | 2014 | 164 | 0.560 |
Why?
|
Lentivirus | 5 | 2009 | 506 | 0.560 |
Why?
|
Bone Marrow Transplantation | 15 | 2007 | 2693 | 0.550 |
Why?
|
Cancer Vaccines | 14 | 2013 | 1046 | 0.520 |
Why?
|
Adenoviridae | 12 | 2008 | 1084 | 0.440 |
Why?
|
Globins | 7 | 1995 | 403 | 0.440 |
Why?
|
Bone Marrow Cells | 9 | 2007 | 2414 | 0.430 |
Why?
|
Genes | 13 | 1994 | 1845 | 0.420 |
Why?
|
Receptors, Growth Factor | 4 | 2002 | 326 | 0.410 |
Why?
|
beta-Galactosidase | 12 | 2006 | 575 | 0.400 |
Why?
|
Mice | 130 | 2011 | 81208 | 0.380 |
Why?
|
Melanoma, Experimental | 5 | 2007 | 562 | 0.380 |
Why?
|
Gene Expression Regulation | 23 | 2007 | 11903 | 0.360 |
Why?
|
Animal Experimentation | 1 | 2010 | 46 | 0.350 |
Why?
|
Vascular Endothelial Growth Factor Receptor-2 | 4 | 2008 | 544 | 0.340 |
Why?
|
Animals | 159 | 2011 | 167963 | 0.320 |
Why?
|
Brain Mapping | 3 | 2014 | 6568 | 0.320 |
Why?
|
Reward | 2 | 2014 | 963 | 0.310 |
Why?
|
Hematopoietic Stem Cell Transplantation | 11 | 2013 | 5649 | 0.310 |
Why?
|
Cell Line | 40 | 2009 | 15620 | 0.300 |
Why?
|
Peptide Chain Termination, Translational | 1 | 2006 | 29 | 0.280 |
Why?
|
Tumor Cells, Cultured | 19 | 2007 | 6131 | 0.280 |
Why?
|
Adenosine Deaminase | 4 | 1997 | 251 | 0.270 |
Why?
|
Transgenes | 2 | 2006 | 1006 | 0.270 |
Why?
|
Hematopoiesis | 8 | 2005 | 2050 | 0.260 |
Why?
|
Codon, Terminator | 1 | 2006 | 125 | 0.260 |
Why?
|
Receptor Protein-Tyrosine Kinases | 4 | 2002 | 1613 | 0.260 |
Why?
|
RNA Processing, Post-Transcriptional | 1 | 2009 | 415 | 0.260 |
Why?
|
Biological Assay | 1 | 2009 | 630 | 0.260 |
Why?
|
Executive Function | 1 | 2014 | 1374 | 0.260 |
Why?
|
Antigens, Neoplasm | 8 | 2007 | 1998 | 0.250 |
Why?
|
Proviruses | 2 | 2005 | 313 | 0.250 |
Why?
|
Publishing | 3 | 2010 | 836 | 0.240 |
Why?
|
Recombination, Genetic | 10 | 2001 | 1526 | 0.240 |
Why?
|
Intelligence | 2 | 2011 | 921 | 0.240 |
Why?
|
DNA, Recombinant | 11 | 1989 | 455 | 0.240 |
Why?
|
Cognition Disorders | 2 | 2011 | 3976 | 0.230 |
Why?
|
Sick Role | 1 | 2005 | 230 | 0.230 |
Why?
|
Guidelines as Topic | 1 | 2010 | 1392 | 0.220 |
Why?
|
Language | 2 | 2005 | 1533 | 0.220 |
Why?
|
Dependovirus | 4 | 2012 | 709 | 0.220 |
Why?
|
Blood Vessel Prosthesis | 3 | 2002 | 956 | 0.220 |
Why?
|
Plasminogen Activator Inhibitor 1 | 5 | 1995 | 278 | 0.220 |
Why?
|
Small Molecule Libraries | 1 | 2009 | 734 | 0.210 |
Why?
|
Recombinant Fusion Proteins | 8 | 2002 | 3735 | 0.210 |
Why?
|
Mice, Inbred C57BL | 28 | 2009 | 22023 | 0.210 |
Why?
|
Immunologic Deficiency Syndromes | 1 | 2006 | 557 | 0.210 |
Why?
|
RNA | 6 | 2011 | 2722 | 0.210 |
Why?
|
Graft Occlusion, Vascular | 2 | 2003 | 560 | 0.210 |
Why?
|
Pulmonary Alveoli | 1 | 2005 | 653 | 0.210 |
Why?
|
Gene Expression Regulation, Enzymologic | 2 | 2006 | 1173 | 0.200 |
Why?
|
Cells, Cultured | 43 | 2009 | 18957 | 0.200 |
Why?
|
Endothelium, Vascular | 9 | 2005 | 4433 | 0.200 |
Why?
|
Impulsive Behavior | 2 | 2014 | 346 | 0.200 |
Why?
|
Genes, Reporter | 5 | 2009 | 1529 | 0.200 |
Why?
|
Respiratory Mucosa | 1 | 2005 | 441 | 0.200 |
Why?
|
Interleukin-3 | 5 | 1998 | 425 | 0.200 |
Why?
|
Dendritic Cells | 5 | 2003 | 2725 | 0.190 |
Why?
|
Brain | 8 | 2014 | 26951 | 0.190 |
Why?
|
Fibrinolysis | 5 | 1996 | 332 | 0.190 |
Why?
|
Simian virus 40 | 9 | 1992 | 291 | 0.190 |
Why?
|
Proto-Oncogene Proteins | 5 | 2006 | 4490 | 0.180 |
Why?
|
Cell Division | 15 | 2004 | 4463 | 0.180 |
Why?
|
Genes, Viral | 10 | 1988 | 650 | 0.180 |
Why?
|
Neovascularization, Pathologic | 7 | 2008 | 2640 | 0.180 |
Why?
|
Periodicals as Topic | 2 | 2010 | 1469 | 0.180 |
Why?
|
Embryonic and Fetal Development | 3 | 2001 | 420 | 0.180 |
Why?
|
Sarcoglycans | 2 | 2012 | 57 | 0.180 |
Why?
|
Vesicular stomatitis Indiana virus | 2 | 1999 | 92 | 0.180 |
Why?
|
Liver | 8 | 2011 | 7509 | 0.180 |
Why?
|
Base Sequence | 23 | 2007 | 12446 | 0.180 |
Why?
|
Attention Deficit Disorder with Hyperactivity | 2 | 2015 | 3701 | 0.180 |
Why?
|
Luminescent Proteins | 3 | 2006 | 835 | 0.180 |
Why?
|
Plasminogen Activators | 3 | 1996 | 199 | 0.170 |
Why?
|
T-Lymphocytes, Cytotoxic | 4 | 2002 | 1765 | 0.170 |
Why?
|
Muscular Dystrophies, Limb-Girdle | 2 | 2012 | 62 | 0.170 |
Why?
|
Transformation, Genetic | 6 | 1992 | 192 | 0.170 |
Why?
|
Gene Expression | 16 | 2009 | 7588 | 0.170 |
Why?
|
Muscular Dystrophy, Animal | 1 | 1999 | 88 | 0.170 |
Why?
|
Lymphocytes | 7 | 2006 | 2611 | 0.160 |
Why?
|
Mice, Inbred Strains | 11 | 2007 | 1763 | 0.160 |
Why?
|
Proto-Oncogene Proteins c-abl | 2 | 2006 | 140 | 0.160 |
Why?
|
Nucleoside Deaminases | 2 | 1990 | 58 | 0.160 |
Why?
|
Dystrophin | 1 | 1999 | 284 | 0.150 |
Why?
|
Viral Envelope Proteins | 3 | 2009 | 638 | 0.150 |
Why?
|
Glycoproteins | 1 | 2005 | 2208 | 0.150 |
Why?
|
Gaucher Disease | 3 | 1995 | 110 | 0.150 |
Why?
|
Immunotherapy | 7 | 2011 | 4642 | 0.150 |
Why?
|
Blotting, Southern | 6 | 1994 | 777 | 0.140 |
Why?
|
Tetrahydrofolate Dehydrogenase | 5 | 1989 | 133 | 0.140 |
Why?
|
Nicotine | 2 | 2014 | 677 | 0.140 |
Why?
|
Molecular Sequence Data | 17 | 2007 | 17624 | 0.140 |
Why?
|
Melanoma | 7 | 2007 | 5697 | 0.140 |
Why?
|
Cell Transformation, Viral | 8 | 1989 | 526 | 0.140 |
Why?
|
3T3 Cells | 8 | 2002 | 1085 | 0.140 |
Why?
|
Plasmids | 14 | 2001 | 2275 | 0.140 |
Why?
|
Enzyme Inhibitors | 2 | 2006 | 3726 | 0.130 |
Why?
|
Toyocamycin | 2 | 2006 | 4 | 0.130 |
Why?
|
Neoplasm Proteins | 5 | 2007 | 3610 | 0.130 |
Why?
|
Membrane Glycoproteins | 7 | 2009 | 3707 | 0.130 |
Why?
|
Humans | 115 | 2015 | 760621 | 0.130 |
Why?
|
Vaccination | 8 | 2013 | 3361 | 0.120 |
Why?
|
Fibrosarcoma | 2 | 1997 | 308 | 0.120 |
Why?
|
Regulatory Sequences, Nucleic Acid | 3 | 1995 | 788 | 0.120 |
Why?
|
Longitudinal Studies | 5 | 2015 | 14495 | 0.120 |
Why?
|
Cloning, Molecular | 13 | 2002 | 4169 | 0.120 |
Why?
|
Embryo, Mammalian | 5 | 2005 | 1674 | 0.120 |
Why?
|
Genes, Lethal | 2 | 1994 | 225 | 0.120 |
Why?
|
Nuclear Proteins | 3 | 2006 | 5791 | 0.120 |
Why?
|
Neovascularization, Physiologic | 4 | 2008 | 1336 | 0.120 |
Why?
|
Pancreatic Neoplasms | 2 | 2002 | 5351 | 0.120 |
Why?
|
Bone Marrow | 6 | 2005 | 2912 | 0.120 |
Why?
|
Hypersensitivity, Delayed | 7 | 2003 | 490 | 0.120 |
Why?
|
Endothelial Growth Factors | 3 | 2002 | 673 | 0.120 |
Why?
|
Social Control, Informal | 1 | 2014 | 44 | 0.120 |
Why?
|
Research Design | 1 | 2010 | 6180 | 0.120 |
Why?
|
Interleukin-12 | 1 | 1997 | 584 | 0.120 |
Why?
|
Urokinase-Type Plasminogen Activator | 4 | 1996 | 326 | 0.120 |
Why?
|
Twins | 1 | 2015 | 339 | 0.120 |
Why?
|
Immunotherapy, Adoptive | 3 | 2007 | 1454 | 0.110 |
Why?
|
Lymphokines | 3 | 2002 | 927 | 0.110 |
Why?
|
Geriatric Assessment | 1 | 2001 | 1405 | 0.110 |
Why?
|
Diseases in Twins | 1 | 2015 | 447 | 0.110 |
Why?
|
Green Fluorescent Proteins | 5 | 2010 | 2057 | 0.110 |
Why?
|
Cell Separation | 5 | 2004 | 1720 | 0.110 |
Why?
|
Conditioning, Operant | 1 | 2014 | 308 | 0.110 |
Why?
|
Methotrexate | 3 | 1989 | 1719 | 0.110 |
Why?
|
Epithelial Cells | 1 | 2005 | 3663 | 0.110 |
Why?
|
Mice, Inbred BALB C | 10 | 2011 | 6216 | 0.110 |
Why?
|
Cytomegalovirus | 2 | 2008 | 755 | 0.110 |
Why?
|
Receptors, Vascular Endothelial Growth Factor | 5 | 2006 | 666 | 0.110 |
Why?
|
HLA-D Antigens | 3 | 1987 | 134 | 0.110 |
Why?
|
Recombinant Proteins | 7 | 2008 | 6538 | 0.110 |
Why?
|
Parathyroid Hormone | 5 | 1996 | 1797 | 0.110 |
Why?
|
Pentosyltransferases | 3 | 1981 | 62 | 0.110 |
Why?
|
RNA Splicing | 6 | 1996 | 915 | 0.110 |
Why?
|
Genomic Instability | 2 | 2008 | 704 | 0.100 |
Why?
|
Leptin | 1 | 2001 | 1591 | 0.100 |
Why?
|
DNA | 18 | 2004 | 7233 | 0.100 |
Why?
|
Oxygen | 3 | 2014 | 4193 | 0.100 |
Why?
|
Muscle, Skeletal | 4 | 2008 | 4925 | 0.100 |
Why?
|
Osteochondrodysplasias | 1 | 1994 | 182 | 0.100 |
Why?
|
Graft Survival | 6 | 2005 | 3794 | 0.100 |
Why?
|
Kidney Neoplasms | 6 | 2004 | 4312 | 0.100 |
Why?
|
Carcinoma, Renal Cell | 5 | 2004 | 3218 | 0.100 |
Why?
|
Memory, Short-Term | 2 | 2010 | 978 | 0.100 |
Why?
|
Transplantation, Heterologous | 7 | 2008 | 2379 | 0.100 |
Why?
|
Kidney | 6 | 2000 | 7064 | 0.100 |
Why?
|
Leukemia, Erythroblastic, Acute | 4 | 1995 | 176 | 0.100 |
Why?
|
Wisconsin | 1 | 2011 | 122 | 0.100 |
Why?
|
Viral Proteins | 4 | 1988 | 1802 | 0.100 |
Why?
|
Transcription, Genetic | 15 | 2002 | 7593 | 0.100 |
Why?
|
HLA-DR Antigens | 4 | 2004 | 630 | 0.100 |
Why?
|
Immunotherapy, Active | 2 | 2006 | 59 | 0.100 |
Why?
|
Avian leukosis virus | 2 | 2001 | 20 | 0.090 |
Why?
|
T-Lymphocytes | 11 | 2009 | 10181 | 0.090 |
Why?
|
Dementia | 2 | 2005 | 2649 | 0.090 |
Why?
|
Luciferases | 2 | 2006 | 716 | 0.090 |
Why?
|
Proteins | 6 | 2008 | 6029 | 0.090 |
Why?
|
Leukemia Virus, Murine | 3 | 1989 | 94 | 0.090 |
Why?
|
Transplantation, Autologous | 6 | 2013 | 2116 | 0.090 |
Why?
|
Genetic Markers | 2 | 2005 | 2608 | 0.090 |
Why?
|
RNA, Messenger | 17 | 2008 | 12766 | 0.090 |
Why?
|
Social Environment | 1 | 2015 | 1022 | 0.090 |
Why?
|
Interleukin-2 | 4 | 1996 | 1889 | 0.090 |
Why?
|
CD8-Positive T-Lymphocytes | 3 | 2013 | 4550 | 0.090 |
Why?
|
Suppression, Genetic | 1 | 1990 | 190 | 0.090 |
Why?
|
Adenosine | 2 | 2006 | 834 | 0.090 |
Why?
|
Growth Hormone | 2 | 1994 | 568 | 0.090 |
Why?
|
Epidermis | 3 | 1994 | 529 | 0.090 |
Why?
|
Cell Line, Transformed | 5 | 2007 | 869 | 0.090 |
Why?
|
Female | 51 | 2015 | 391270 | 0.090 |
Why?
|
Mice, Transgenic | 11 | 2006 | 9530 | 0.090 |
Why?
|
Endostatins | 2 | 2008 | 168 | 0.090 |
Why?
|
Male | 49 | 2015 | 359744 | 0.080 |
Why?
|
Adenocarcinoma | 3 | 2002 | 6315 | 0.080 |
Why?
|
Major Histocompatibility Complex | 3 | 1987 | 928 | 0.080 |
Why?
|
Clone Cells | 4 | 2009 | 1660 | 0.080 |
Why?
|
Wechsler Scales | 2 | 2012 | 257 | 0.080 |
Why?
|
Receptors, LDL | 2 | 1990 | 488 | 0.080 |
Why?
|
Weight Loss | 1 | 2001 | 2686 | 0.080 |
Why?
|
Tissue Plasminogen Activator | 4 | 1996 | 1190 | 0.080 |
Why?
|
Neostriatum | 1 | 2010 | 246 | 0.080 |
Why?
|
Decision Making | 2 | 2014 | 3925 | 0.080 |
Why?
|
Antigens, Differentiation | 2 | 2004 | 911 | 0.080 |
Why?
|
Receptors, Interleukin-2 | 2 | 1990 | 562 | 0.080 |
Why?
|
Mice, Nude | 6 | 2008 | 3607 | 0.080 |
Why?
|
alpha 1-Antitrypsin | 1 | 2009 | 169 | 0.080 |
Why?
|
Cues | 1 | 2014 | 867 | 0.080 |
Why?
|
Glucosylceramidase | 4 | 1996 | 125 | 0.080 |
Why?
|
Mouth Diseases | 2 | 2001 | 238 | 0.080 |
Why?
|
Promoter Regions, Genetic | 12 | 2008 | 5785 | 0.080 |
Why?
|
Immunization | 1 | 1993 | 1227 | 0.080 |
Why?
|
Glioblastoma | 3 | 2009 | 3484 | 0.080 |
Why?
|
Choice Behavior | 1 | 2014 | 821 | 0.080 |
Why?
|
Cell Movement | 5 | 2004 | 5206 | 0.080 |
Why?
|
Cell Transplantation | 5 | 2002 | 472 | 0.080 |
Why?
|
Nicotinic Agonists | 1 | 2010 | 265 | 0.080 |
Why?
|
Arteries | 2 | 1996 | 1126 | 0.080 |
Why?
|
Pattern Recognition, Physiological | 1 | 2007 | 13 | 0.080 |
Why?
|
Fluorouracil | 3 | 2006 | 1631 | 0.080 |
Why?
|
Verbal Learning | 1 | 2010 | 462 | 0.070 |
Why?
|
Amygdala | 2 | 2014 | 1351 | 0.070 |
Why?
|
Retinoblastoma | 1 | 1990 | 317 | 0.070 |
Why?
|
Reproducibility of Results | 4 | 2014 | 20080 | 0.070 |
Why?
|
Receptor, Platelet-Derived Growth Factor beta | 1 | 2008 | 184 | 0.070 |
Why?
|
Vascular Endothelial Growth Factor A | 5 | 2007 | 3484 | 0.070 |
Why?
|
Macrophages, Alveolar | 1 | 2009 | 409 | 0.070 |
Why?
|
Leukemia | 1 | 1995 | 1520 | 0.070 |
Why?
|
Immunoglobulin lambda-Chains | 1 | 1987 | 82 | 0.070 |
Why?
|
Receptors, Virus | 2 | 2001 | 639 | 0.070 |
Why?
|
Islets of Langerhans Transplantation | 2 | 2004 | 739 | 0.070 |
Why?
|
Phosphoproteins | 3 | 2004 | 2440 | 0.070 |
Why?
|
Emphysema | 1 | 2009 | 240 | 0.070 |
Why?
|
Blastocyst | 2 | 1989 | 433 | 0.070 |
Why?
|
Organ Specificity | 3 | 2004 | 1955 | 0.070 |
Why?
|
Mice, Knockout | 11 | 2008 | 14372 | 0.070 |
Why?
|
Focal Adhesion Protein-Tyrosine Kinases | 1 | 2007 | 186 | 0.070 |
Why?
|
Neoplasms, Experimental | 3 | 2008 | 1229 | 0.070 |
Why?
|
Tubercidin | 1 | 2006 | 15 | 0.070 |
Why?
|
Acridine Orange | 1 | 2006 | 28 | 0.070 |
Why?
|
Ethidium | 1 | 2006 | 27 | 0.070 |
Why?
|
Phonetics | 1 | 2007 | 198 | 0.070 |
Why?
|
Schistosoma mansoni | 1 | 2007 | 156 | 0.070 |
Why?
|
Verbal Behavior | 1 | 2007 | 335 | 0.070 |
Why?
|
Pulmonary Surfactants | 3 | 1996 | 161 | 0.070 |
Why?
|
Luciferases, Firefly | 1 | 2006 | 37 | 0.070 |
Why?
|
Bone Marrow Diseases | 1 | 2008 | 232 | 0.070 |
Why?
|
Cytidine | 1 | 2006 | 65 | 0.070 |
Why?
|
Oligonucleotides, Antisense | 1 | 2009 | 459 | 0.070 |
Why?
|
Neuropsychological Tests | 4 | 2012 | 7021 | 0.070 |
Why?
|
Rabbits | 10 | 2003 | 4773 | 0.070 |
Why?
|
Antigens, CD34 | 4 | 2004 | 653 | 0.060 |
Why?
|
Mice, Inbred C3H | 4 | 1997 | 915 | 0.060 |
Why?
|
Vascular Endothelial Growth Factors | 3 | 2002 | 748 | 0.060 |
Why?
|
Aminoglycosides | 1 | 2006 | 163 | 0.060 |
Why?
|
PPAR alpha | 1 | 2007 | 174 | 0.060 |
Why?
|
Uridine | 1 | 2006 | 143 | 0.060 |
Why?
|
Pulmonary Surfactant-Associated Protein C | 1 | 2005 | 30 | 0.060 |
Why?
|
Biomimetics | 1 | 2007 | 173 | 0.060 |
Why?
|
Chemokines, CXC | 1 | 2007 | 421 | 0.060 |
Why?
|
Gentamicins | 1 | 2006 | 252 | 0.060 |
Why?
|
Precursor B-Cell Lymphoblastic Leukemia-Lymphoma | 1 | 2007 | 223 | 0.060 |
Why?
|
Solubility | 2 | 2008 | 1088 | 0.060 |
Why?
|
Substance Withdrawal Syndrome | 1 | 2010 | 622 | 0.060 |
Why?
|
Blotting, Western | 6 | 2001 | 5039 | 0.060 |
Why?
|
Amino Acid Sequence | 11 | 2002 | 13451 | 0.060 |
Why?
|
Transplantation Chimera | 2 | 2005 | 595 | 0.060 |
Why?
|
Genes, Bacterial | 4 | 1985 | 1071 | 0.060 |
Why?
|
Radiation Chimera | 4 | 2007 | 216 | 0.060 |
Why?
|
Papillomaviridae | 2 | 1988 | 1117 | 0.060 |
Why?
|
Attention | 1 | 2015 | 2387 | 0.060 |
Why?
|
Spleen | 4 | 1996 | 2298 | 0.060 |
Why?
|
Acetanilides | 1 | 2006 | 169 | 0.060 |
Why?
|
Granulocytes | 1 | 2007 | 551 | 0.060 |
Why?
|
K562 Cells | 3 | 2013 | 640 | 0.060 |
Why?
|
Genetic Association Studies | 1 | 2014 | 2717 | 0.060 |
Why?
|
Pulmonary Alveolar Proteinosis | 2 | 1996 | 40 | 0.060 |
Why?
|
Guanine | 1 | 2006 | 278 | 0.060 |
Why?
|
Aging | 4 | 2014 | 8651 | 0.060 |
Why?
|
Family | 1 | 2015 | 3189 | 0.060 |
Why?
|
Telomere | 1 | 2011 | 933 | 0.060 |
Why?
|
Hypoxanthine Phosphoribosyltransferase | 2 | 1981 | 69 | 0.060 |
Why?
|
Immunoconjugates | 2 | 2004 | 949 | 0.060 |
Why?
|
Base Pairing | 1 | 2004 | 140 | 0.060 |
Why?
|
Magnetic Resonance Imaging | 8 | 2014 | 36290 | 0.060 |
Why?
|
DNA, Viral | 8 | 1989 | 2194 | 0.060 |
Why?
|
Chemotaxis | 1 | 2007 | 598 | 0.060 |
Why?
|
Switzerland | 1 | 2005 | 323 | 0.060 |
Why?
|
Stem Cells | 6 | 2007 | 3523 | 0.060 |
Why?
|
Adenoviruses, Human | 1 | 1985 | 255 | 0.060 |
Why?
|
Endonucleases | 1 | 2006 | 370 | 0.060 |
Why?
|
Adolescent | 11 | 2015 | 87810 | 0.060 |
Why?
|
Interleukin-6 | 4 | 2004 | 3215 | 0.060 |
Why?
|
Genotype | 3 | 2014 | 12960 | 0.060 |
Why?
|
Mast Cells | 2 | 2003 | 1390 | 0.060 |
Why?
|
France | 1 | 2005 | 511 | 0.050 |
Why?
|
Antigen-Presenting Cells | 1 | 2007 | 967 | 0.050 |
Why?
|
Hyperlipoproteinemia Type II | 1 | 1988 | 396 | 0.050 |
Why?
|
Restriction Mapping | 3 | 1993 | 852 | 0.050 |
Why?
|
Lymphangiogenesis | 1 | 2004 | 172 | 0.050 |
Why?
|
Sirtuins | 1 | 2006 | 320 | 0.050 |
Why?
|
Reverse Transcriptase Polymerase Chain Reaction | 3 | 2005 | 4573 | 0.050 |
Why?
|
RNA, Viral | 8 | 2000 | 2838 | 0.050 |
Why?
|
Mice, Mutant Strains | 6 | 1998 | 1753 | 0.050 |
Why?
|
Catalysis | 1 | 2004 | 775 | 0.050 |
Why?
|
DNA Primers | 3 | 1998 | 2819 | 0.050 |
Why?
|
Swine, Miniature | 2 | 2002 | 959 | 0.050 |
Why?
|
Cognition | 2 | 2012 | 6957 | 0.050 |
Why?
|
Splenic Neoplasms | 1 | 2002 | 95 | 0.050 |
Why?
|
Cricetinae | 3 | 2004 | 2427 | 0.050 |
Why?
|
Wiskott-Aldrich Syndrome | 1 | 2002 | 130 | 0.050 |
Why?
|
Fibroblast Growth Factor 2 | 1 | 2004 | 590 | 0.050 |
Why?
|
Receptors, Cell Surface | 2 | 2005 | 2825 | 0.050 |
Why?
|
Antibiotics, Antineoplastic | 1 | 2006 | 675 | 0.050 |
Why?
|
Membrane Proteins | 6 | 2007 | 7850 | 0.050 |
Why?
|
Leukemia, Lymphocytic, Chronic, B-Cell | 1 | 2013 | 1628 | 0.050 |
Why?
|
Cytokines | 5 | 2009 | 7343 | 0.050 |
Why?
|
Molecular Weight | 3 | 1990 | 2186 | 0.050 |
Why?
|
Erythropoietin | 1 | 2006 | 720 | 0.050 |
Why?
|
Depression | 1 | 2001 | 8044 | 0.050 |
Why?
|
Species Specificity | 5 | 2004 | 2418 | 0.050 |
Why?
|
Cell Surface Extensions | 1 | 2001 | 66 | 0.050 |
Why?
|
Molecular Structure | 1 | 2006 | 1895 | 0.050 |
Why?
|
Receptors, IgE | 1 | 2003 | 372 | 0.050 |
Why?
|
Tunica Intima | 1 | 2003 | 459 | 0.050 |
Why?
|
Blood Vessels | 2 | 2005 | 1112 | 0.050 |
Why?
|
Nitric Oxide Synthase | 1 | 2004 | 908 | 0.050 |
Why?
|
Cartilage | 2 | 1996 | 806 | 0.050 |
Why?
|
Actins | 2 | 2001 | 2049 | 0.050 |
Why?
|
Gene Targeting | 4 | 2001 | 839 | 0.050 |
Why?
|
Oligonucleotides | 1 | 2004 | 588 | 0.050 |
Why?
|
Antigens, Ly | 2 | 2007 | 292 | 0.050 |
Why?
|
Cell Line, Tumor | 6 | 2011 | 16939 | 0.050 |
Why?
|
Genetic Complementation Test | 2 | 2000 | 555 | 0.050 |
Why?
|
Glucokinase | 1 | 2001 | 102 | 0.050 |
Why?
|
Wound Healing | 2 | 2007 | 2788 | 0.050 |
Why?
|
Prostatic Neoplasms | 5 | 2006 | 11345 | 0.050 |
Why?
|
Reading | 1 | 2005 | 529 | 0.050 |
Why?
|
Colonic Neoplasms | 1 | 1993 | 2526 | 0.050 |
Why?
|
Genetic Diseases, Inborn | 1 | 2006 | 601 | 0.050 |
Why?
|
B-Lymphocytes | 4 | 2007 | 4742 | 0.050 |
Why?
|
Phenotype | 7 | 2015 | 16546 | 0.050 |
Why?
|
Lesch-Nyhan Syndrome | 1 | 1980 | 16 | 0.050 |
Why?
|
DNA-Binding Proteins | 4 | 2006 | 9585 | 0.050 |
Why?
|
Imaging, Three-Dimensional | 1 | 2014 | 4048 | 0.050 |
Why?
|
Adaptor Proteins, Signal Transducing | 3 | 2006 | 2895 | 0.050 |
Why?
|
Frontal Lobe | 1 | 2007 | 1420 | 0.050 |
Why?
|
Adoptive Transfer | 1 | 2003 | 822 | 0.050 |
Why?
|
Fluorescent Dyes | 5 | 2004 | 1913 | 0.050 |
Why?
|
Medulloblastoma | 1 | 2006 | 679 | 0.050 |
Why?
|
Benzimidazoles | 4 | 2002 | 858 | 0.050 |
Why?
|
Clinical Trials, Phase I as Topic | 1 | 2002 | 326 | 0.050 |
Why?
|
Drug Evaluation, Preclinical | 1 | 2006 | 1347 | 0.050 |
Why?
|
DNA Restriction Enzymes | 7 | 1987 | 553 | 0.050 |
Why?
|
Cell Adhesion | 1 | 2007 | 3094 | 0.040 |
Why?
|
Collagen | 3 | 2001 | 2636 | 0.040 |
Why?
|
Mice, Congenic | 1 | 2000 | 97 | 0.040 |
Why?
|
Translocation, Genetic | 1 | 2006 | 1388 | 0.040 |
Why?
|
Melanoma-Specific Antigens | 1 | 2000 | 74 | 0.040 |
Why?
|
AIDS-Related Opportunistic Infections | 2 | 2001 | 662 | 0.040 |
Why?
|
Cerebellum | 1 | 2007 | 1496 | 0.040 |
Why?
|
Antigens, CD | 4 | 2004 | 4000 | 0.040 |
Why?
|
Extracellular Matrix | 4 | 2001 | 1726 | 0.040 |
Why?
|
Nucleic Acid Hybridization | 4 | 1989 | 1304 | 0.040 |
Why?
|
Cell Differentiation | 10 | 2007 | 11481 | 0.040 |
Why?
|
Mice, Obese | 1 | 2001 | 420 | 0.040 |
Why?
|
Xerostomia | 1 | 2000 | 94 | 0.040 |
Why?
|
Cultural Characteristics | 1 | 2001 | 253 | 0.040 |
Why?
|
Thrombosis | 4 | 2002 | 3052 | 0.040 |
Why?
|
Tumor Suppressor Protein p53 | 2 | 2011 | 2919 | 0.040 |
Why?
|
Capillary Permeability | 2 | 2000 | 768 | 0.040 |
Why?
|
Clinical Trials, Phase II as Topic | 1 | 2002 | 629 | 0.040 |
Why?
|
Monosaccharide Transport Proteins | 1 | 2001 | 440 | 0.040 |
Why?
|
Image Processing, Computer-Assisted | 3 | 2011 | 8950 | 0.040 |
Why?
|
Injections, Intramuscular | 2 | 1999 | 553 | 0.040 |
Why?
|
Neoplasms | 5 | 2011 | 22072 | 0.040 |
Why?
|
Polyglycolic Acid | 1 | 2001 | 405 | 0.040 |
Why?
|
HeLa Cells | 3 | 2002 | 3105 | 0.040 |
Why?
|
Proteolipids | 2 | 1996 | 113 | 0.040 |
Why?
|
Adenoviridae Infections | 1 | 1999 | 93 | 0.040 |
Why?
|
Protein-Tyrosine Kinases | 2 | 2004 | 2418 | 0.040 |
Why?
|
Brain Neoplasms | 3 | 2008 | 8986 | 0.040 |
Why?
|
Macrophage Colony-Stimulating Factor | 2 | 1996 | 186 | 0.040 |
Why?
|
Homozygote | 3 | 1993 | 1788 | 0.040 |
Why?
|
Erythrocytes | 1 | 1988 | 2415 | 0.040 |
Why?
|
Evaluation Studies as Topic | 1 | 2001 | 1628 | 0.040 |
Why?
|
Mutagenesis | 3 | 2004 | 1234 | 0.040 |
Why?
|
Cell Lineage | 2 | 2005 | 2533 | 0.040 |
Why?
|
Lymph Nodes | 2 | 2003 | 3486 | 0.040 |
Why?
|
Obesity | 1 | 2001 | 12922 | 0.040 |
Why?
|
Pituitary Gland | 1 | 2001 | 637 | 0.040 |
Why?
|
CD4 Lymphocyte Count | 4 | 2012 | 2569 | 0.040 |
Why?
|
Cerebral Ventricles | 1 | 2001 | 542 | 0.040 |
Why?
|
Escherichia coli | 5 | 1988 | 4219 | 0.040 |
Why?
|
Fibroblasts | 6 | 2005 | 4090 | 0.040 |
Why?
|
Strongyloidiasis | 1 | 1998 | 27 | 0.040 |
Why?
|
Kanamycin Kinase | 3 | 1987 | 34 | 0.040 |
Why?
|
Angiogenesis Inhibitors | 2 | 2006 | 2049 | 0.040 |
Why?
|
Gene Deletion | 3 | 1996 | 2668 | 0.040 |
Why?
|
HIV Infections | 4 | 2012 | 17165 | 0.040 |
Why?
|
Mice, Inbred CBA | 2 | 1989 | 436 | 0.040 |
Why?
|
Genes, Tumor Suppressor | 1 | 2002 | 1055 | 0.040 |
Why?
|
Mitochondria | 1 | 2011 | 3600 | 0.040 |
Why?
|
Vascular Endothelial Growth Factor Receptor-1 | 1 | 2001 | 558 | 0.040 |
Why?
|
Protein Structure, Tertiary | 2 | 2003 | 3800 | 0.040 |
Why?
|
Polymerase Chain Reaction | 3 | 1996 | 6068 | 0.040 |
Why?
|
Xenograft Model Antitumor Assays | 1 | 2006 | 3584 | 0.040 |
Why?
|
Leg | 1 | 2002 | 1090 | 0.040 |
Why?
|
Fibrin | 3 | 1995 | 505 | 0.040 |
Why?
|
Mammary Neoplasms, Experimental | 1 | 2000 | 507 | 0.040 |
Why?
|
Trans-Activators | 2 | 1997 | 2860 | 0.040 |
Why?
|
Macaca mulatta | 4 | 2010 | 2316 | 0.040 |
Why?
|
Mutation | 9 | 1993 | 29932 | 0.040 |
Why?
|
Endothelial Cells | 3 | 2005 | 3539 | 0.040 |
Why?
|
Creatine Kinase | 2 | 2008 | 691 | 0.040 |
Why?
|
Vaccines, Synthetic | 1 | 1999 | 617 | 0.030 |
Why?
|
Mice, Inbred DBA | 1 | 1998 | 622 | 0.030 |
Why?
|
Transforming Growth Factor beta | 1 | 2004 | 1959 | 0.030 |
Why?
|
Staining and Labeling | 2 | 2004 | 1089 | 0.030 |
Why?
|
Tetracycline | 1 | 1997 | 220 | 0.030 |
Why?
|
Enhancer Elements, Genetic | 3 | 1989 | 1356 | 0.030 |
Why?
|
Stress, Psychological | 1 | 2012 | 4446 | 0.030 |
Why?
|
Lymphocyte Activation | 5 | 2002 | 5496 | 0.030 |
Why?
|
Heparitin Sulfate | 2 | 1994 | 224 | 0.030 |
Why?
|
Phosphorylation | 5 | 2007 | 8313 | 0.030 |
Why?
|
Phosphotransferases | 3 | 1987 | 303 | 0.030 |
Why?
|
Enzyme-Linked Immunosorbent Assay | 3 | 2003 | 3804 | 0.030 |
Why?
|
Flow Cytometry | 2 | 2009 | 5870 | 0.030 |
Why?
|
Capsid | 1 | 1999 | 434 | 0.030 |
Why?
|
Models, Genetic | 1 | 2006 | 3442 | 0.030 |
Why?
|
Receptors, Antigen, T-Cell | 2 | 2002 | 2536 | 0.030 |
Why?
|
Parathyroid Hormone-Related Protein | 2 | 1996 | 327 | 0.030 |
Why?
|
Carotid Stenosis | 1 | 2003 | 878 | 0.030 |
Why?
|
RNA-Directed DNA Polymerase | 1 | 1996 | 224 | 0.030 |
Why?
|
Priapism | 1 | 1996 | 29 | 0.030 |
Why?
|
Mutagenesis, Site-Directed | 2 | 2003 | 1693 | 0.030 |
Why?
|
Macrophages | 6 | 1998 | 5745 | 0.030 |
Why?
|
Kidney Glomerulus | 2 | 2000 | 568 | 0.030 |
Why?
|
Thrombopoietin | 1 | 1998 | 226 | 0.030 |
Why?
|
Adult | 17 | 2014 | 219994 | 0.030 |
Why?
|
Reperfusion Injury | 1 | 2002 | 1023 | 0.030 |
Why?
|
Apoptosis | 3 | 2008 | 9501 | 0.030 |
Why?
|
Dose-Response Relationship, Drug | 4 | 2004 | 10827 | 0.030 |
Why?
|
Fanconi Anemia | 1 | 1998 | 324 | 0.030 |
Why?
|
Basophils | 1 | 1998 | 404 | 0.030 |
Why?
|
Lung Neoplasms | 3 | 2004 | 13262 | 0.030 |
Why?
|
Verapamil | 1 | 1996 | 242 | 0.030 |
Why?
|
Hypothalamus | 1 | 2001 | 998 | 0.030 |
Why?
|
Lactic Acid | 1 | 2001 | 1134 | 0.030 |
Why?
|
DNA, Bacterial | 1 | 1980 | 1456 | 0.030 |
Why?
|
Receptors, Parathyroid Hormone | 1 | 1996 | 332 | 0.030 |
Why?
|
Plastic Embedding | 1 | 1995 | 8 | 0.030 |
Why?
|
Immunohistochemistry | 4 | 2010 | 11071 | 0.030 |
Why?
|
Protein Biosynthesis | 5 | 1996 | 2105 | 0.030 |
Why?
|
Signal Transduction | 8 | 2008 | 23376 | 0.030 |
Why?
|
DNA, Complementary | 2 | 1993 | 1991 | 0.030 |
Why?
|
Nitric Oxide | 1 | 2004 | 2141 | 0.030 |
Why?
|
Rats | 11 | 2004 | 23711 | 0.030 |
Why?
|
Lymphocyte Depletion | 2 | 1997 | 602 | 0.030 |
Why?
|
Leukemia, Experimental | 1 | 1995 | 225 | 0.030 |
Why?
|
Mice, Neurologic Mutants | 1 | 1995 | 107 | 0.030 |
Why?
|
Glucosylceramides | 1 | 1995 | 28 | 0.030 |
Why?
|
Kidney Diseases | 2 | 1996 | 2093 | 0.030 |
Why?
|
Chickens | 2 | 1995 | 860 | 0.030 |
Why?
|
Tissue Engineering | 1 | 2005 | 1870 | 0.030 |
Why?
|
Ovulation | 1 | 1995 | 181 | 0.030 |
Why?
|
Neoplasm Metastasis | 3 | 2003 | 4902 | 0.030 |
Why?
|
Repetitive Sequences, Nucleic Acid | 4 | 1992 | 783 | 0.030 |
Why?
|
Penis | 1 | 1996 | 212 | 0.030 |
Why?
|
Middle Aged | 20 | 2014 | 220352 | 0.030 |
Why?
|
Colony-Forming Units Assay | 2 | 2007 | 351 | 0.030 |
Why?
|
Long-Term Potentiation | 1 | 1996 | 293 | 0.030 |
Why?
|
Erythroid Precursor Cells | 1 | 1995 | 211 | 0.030 |
Why?
|
Growth Plate | 1 | 1996 | 274 | 0.030 |
Why?
|
Oxidative Stress | 2 | 2002 | 3106 | 0.030 |
Why?
|
Nucleic Acid Conformation | 2 | 2007 | 899 | 0.030 |
Why?
|
Proteoglycans | 2 | 1994 | 801 | 0.030 |
Why?
|
Culture Media | 1 | 1996 | 900 | 0.030 |
Why?
|
Animals, Newborn | 2 | 1991 | 2672 | 0.030 |
Why?
|
Drug Screening Assays, Antitumor | 1 | 1997 | 717 | 0.030 |
Why?
|
Diagnostic Errors | 1 | 2001 | 1266 | 0.030 |
Why?
|
Blood | 1 | 1996 | 586 | 0.030 |
Why?
|
HIV | 2 | 2004 | 1579 | 0.030 |
Why?
|
Drug Resistance | 4 | 1988 | 1617 | 0.030 |
Why?
|
Alleles | 3 | 2014 | 6898 | 0.030 |
Why?
|
Dogs | 2 | 1989 | 3841 | 0.030 |
Why?
|
Colitis | 1 | 2002 | 1229 | 0.030 |
Why?
|
In Situ Nick-End Labeling | 2 | 2008 | 613 | 0.030 |
Why?
|
Individuality | 1 | 2015 | 300 | 0.030 |
Why?
|
Histocompatibility Antigens Class I | 1 | 2000 | 1355 | 0.030 |
Why?
|
Thymus Gland | 2 | 1991 | 1247 | 0.030 |
Why?
|
Immunosuppressive Agents | 2 | 2004 | 4166 | 0.030 |
Why?
|
Corneal Neovascularization | 2 | 2007 | 185 | 0.030 |
Why?
|
Tissue Distribution | 3 | 2001 | 2262 | 0.030 |
Why?
|
Fetal Blood | 1 | 2000 | 1343 | 0.030 |
Why?
|
Genomic Library | 1 | 1993 | 189 | 0.030 |
Why?
|
Antineoplastic Agents | 1 | 1997 | 13630 | 0.030 |
Why?
|
Immunoglobulin Joining Region | 1 | 1993 | 37 | 0.030 |
Why?
|
Megakaryocytes | 1 | 1998 | 565 | 0.030 |
Why?
|
Genes, RAG-1 | 1 | 1993 | 67 | 0.030 |
Why?
|
Polymers | 1 | 2001 | 1621 | 0.030 |
Why?
|
Proto-Oncogene Proteins c-bcl-2 | 1 | 2000 | 1407 | 0.030 |
Why?
|
Mice, SCID | 3 | 2006 | 2627 | 0.030 |
Why?
|
Lymphatic Metastasis | 2 | 2002 | 2943 | 0.030 |
Why?
|
Gene Expression Regulation, Viral | 1 | 1996 | 438 | 0.030 |
Why?
|
Lac Operon | 3 | 1999 | 237 | 0.030 |
Why?
|
In Situ Hybridization, Fluorescence | 1 | 1999 | 2506 | 0.030 |
Why?
|
NADH, NADPH Oxidoreductases | 1 | 1993 | 93 | 0.030 |
Why?
|
Autopsy | 1 | 1997 | 1007 | 0.030 |
Why?
|
Bone Development | 1 | 1996 | 472 | 0.030 |
Why?
|
Peptides | 1 | 2005 | 4354 | 0.030 |
Why?
|
Forecasting | 1 | 2002 | 2932 | 0.030 |
Why?
|
Cohort Studies | 2 | 2014 | 41335 | 0.030 |
Why?
|
Nerve Tissue Proteins | 2 | 2006 | 4407 | 0.030 |
Why?
|
Adenosine Triphosphate | 3 | 2011 | 1993 | 0.030 |
Why?
|
Aged | 12 | 2013 | 169152 | 0.030 |
Why?
|
Tissue Transplantation | 1 | 1993 | 128 | 0.030 |
Why?
|
Iliac Artery | 1 | 1994 | 344 | 0.030 |
Why?
|
Fibronectins | 2 | 1987 | 722 | 0.030 |
Why?
|
Granulomatous Disease, Chronic | 1 | 1993 | 173 | 0.030 |
Why?
|
Genes, Immunoglobulin | 1 | 1993 | 285 | 0.030 |
Why?
|
Radiation Protection | 1 | 1996 | 425 | 0.030 |
Why?
|
Human Growth Hormone | 1 | 1997 | 638 | 0.030 |
Why?
|
Eosinophilia | 1 | 1997 | 559 | 0.030 |
Why?
|
Microscopy, Electron, Scanning | 1 | 1994 | 941 | 0.030 |
Why?
|
Growth | 1 | 1994 | 365 | 0.030 |
Why?
|
Analysis of Variance | 3 | 2009 | 6238 | 0.020 |
Why?
|
Tubulin | 2 | 1986 | 692 | 0.020 |
Why?
|
Disease Models, Animal | 5 | 2007 | 18137 | 0.020 |
Why?
|
Bacterial Proteins | 2 | 2001 | 3826 | 0.020 |
Why?
|
Codon | 1 | 1993 | 602 | 0.020 |
Why?
|
Cell Survival | 4 | 2004 | 5797 | 0.020 |
Why?
|
Psychometrics | 1 | 2001 | 3051 | 0.020 |
Why?
|
Phagocytes | 1 | 1993 | 296 | 0.020 |
Why?
|
Interleukin-4 | 1 | 1995 | 1130 | 0.020 |
Why?
|
Glycosaminoglycans | 1 | 1994 | 605 | 0.020 |
Why?
|
Kidney Tubules | 3 | 2000 | 449 | 0.020 |
Why?
|
Cell Culture Techniques | 1 | 1999 | 1664 | 0.020 |
Why?
|
Cell Proliferation | 4 | 2011 | 10446 | 0.020 |
Why?
|
Treatment Outcome | 6 | 2013 | 65017 | 0.020 |
Why?
|
Candidiasis, Oral | 2 | 2001 | 57 | 0.020 |
Why?
|
Ovary | 1 | 1995 | 958 | 0.020 |
Why?
|
Combined Modality Therapy | 3 | 2013 | 8552 | 0.020 |
Why?
|
Microtubules | 2 | 2008 | 1072 | 0.020 |
Why?
|
Kinetics | 4 | 2007 | 6377 | 0.020 |
Why?
|
Neurons | 3 | 2002 | 9426 | 0.020 |
Why?
|
Carrier Proteins | 1 | 2004 | 4938 | 0.020 |
Why?
|
Lymphocytes, Tumor-Infiltrating | 3 | 2004 | 1088 | 0.020 |
Why?
|
Hemostasis | 1 | 1993 | 468 | 0.020 |
Why?
|
Inflammation | 3 | 2009 | 10756 | 0.020 |
Why?
|
Chloramphenicol O-Acetyltransferase | 1 | 1990 | 221 | 0.020 |
Why?
|
Hyperparathyroidism | 1 | 1992 | 339 | 0.020 |
Why?
|
Gene Amplification | 2 | 2006 | 1085 | 0.020 |
Why?
|
Cell Nucleus | 1 | 1999 | 2907 | 0.020 |
Why?
|
Proto-Oncogenes | 1 | 1991 | 320 | 0.020 |
Why?
|
Avian Proteins | 2 | 2001 | 80 | 0.020 |
Why?
|
Immunity, Cellular | 1 | 1996 | 1557 | 0.020 |
Why?
|
Macromolecular Substances | 2 | 1990 | 1433 | 0.020 |
Why?
|
Keratinocytes | 1 | 1994 | 792 | 0.020 |
Why?
|
Statistics as Topic | 1 | 1997 | 2362 | 0.020 |
Why?
|
Mammals | 2 | 2002 | 1131 | 0.020 |
Why?
|
Aged, 80 and over | 3 | 2007 | 58995 | 0.020 |
Why?
|
Prevalence | 2 | 2005 | 15687 | 0.020 |
Why?
|
Antigens, Surface | 2 | 2003 | 1608 | 0.020 |
Why?
|
Gluconeogenesis | 1 | 2011 | 185 | 0.020 |
Why?
|
Hematocrit | 2 | 2006 | 629 | 0.020 |
Why?
|
Femoral Artery | 1 | 1994 | 835 | 0.020 |
Why?
|
Young Adult | 2 | 2014 | 58741 | 0.020 |
Why?
|
Leukocytes, Mononuclear | 2 | 2009 | 1827 | 0.020 |
Why?
|
Proto-Oncogene Proteins c-jun | 1 | 1990 | 285 | 0.020 |
Why?
|
Proto-Oncogene Proteins c-kit | 2 | 2007 | 727 | 0.020 |
Why?
|
Osteogenesis | 1 | 1996 | 1271 | 0.020 |
Why?
|
Survival Analysis | 1 | 2002 | 10182 | 0.020 |
Why?
|
Sensitivity and Specificity | 2 | 2001 | 14660 | 0.020 |
Why?
|
Glucose | 1 | 2001 | 4351 | 0.020 |
Why?
|
Intercellular Adhesion Molecule-1 | 1 | 1993 | 1126 | 0.020 |
Why?
|
Viruses | 1 | 1993 | 376 | 0.020 |
Why?
|
Tryptophan Synthase | 1 | 1988 | 9 | 0.020 |
Why?
|
Hematologic Diseases | 1 | 1993 | 496 | 0.020 |
Why?
|
Lymphopenia | 1 | 1991 | 280 | 0.020 |
Why?
|
Vaccines | 1 | 1998 | 832 | 0.020 |
Why?
|
Hemorrhage | 2 | 2008 | 3600 | 0.020 |
Why?
|
Models, Animal | 2 | 2006 | 2117 | 0.020 |
Why?
|
Helper Viruses | 1 | 1988 | 40 | 0.020 |
Why?
|
Diabetes Mellitus | 1 | 2007 | 5889 | 0.020 |
Why?
|
Cell Death | 2 | 2006 | 1672 | 0.020 |
Why?
|
Tumor Necrosis Factor-alpha | 1 | 2000 | 4357 | 0.020 |
Why?
|
Chlorides | 1 | 1991 | 663 | 0.020 |
Why?
|
Microbodies | 1 | 1988 | 36 | 0.020 |
Why?
|
Cell Transformation, Neoplastic | 3 | 1987 | 2828 | 0.020 |
Why?
|
Glucose-6-Phosphatase | 1 | 1988 | 72 | 0.020 |
Why?
|
Hemin | 1 | 1988 | 50 | 0.020 |
Why?
|
Corpus Luteum | 1 | 2008 | 81 | 0.020 |
Why?
|
Peptide Fragments | 1 | 2001 | 5125 | 0.020 |
Why?
|
Caspase 3 | 1 | 2010 | 731 | 0.020 |
Why?
|
Virus Replication | 2 | 1989 | 2432 | 0.020 |
Why?
|
Sequence Analysis, DNA | 1 | 1999 | 4713 | 0.020 |
Why?
|
Stereotaxic Techniques | 1 | 2010 | 549 | 0.020 |
Why?
|
Alcohol Oxidoreductases | 1 | 1988 | 169 | 0.020 |
Why?
|
Exons | 1 | 2014 | 2388 | 0.020 |
Why?
|
Coculture Techniques | 2 | 2005 | 1342 | 0.020 |
Why?
|
Blood Coagulation | 1 | 1994 | 1157 | 0.020 |
Why?
|
Histidine | 1 | 1988 | 311 | 0.020 |
Why?
|
Neoplasm Recurrence, Local | 1 | 2006 | 9276 | 0.020 |
Why?
|
SELEX Aptamer Technique | 1 | 2007 | 18 | 0.020 |
Why?
|
Regulatory Sequences, Ribonucleic Acid | 1 | 2007 | 29 | 0.020 |
Why?
|
Chromosome Mapping | 3 | 1987 | 4625 | 0.020 |
Why?
|
Proto-Oncogene Proteins c-fos | 1 | 1990 | 586 | 0.020 |
Why?
|
Glucuronosyltransferase | 1 | 1988 | 130 | 0.020 |
Why?
|
R Factors | 1 | 1987 | 44 | 0.020 |
Why?
|
rap1 GTP-Binding Proteins | 1 | 2007 | 51 | 0.020 |
Why?
|
Antigen Presentation | 2 | 2007 | 1254 | 0.020 |
Why?
|
Theophylline | 1 | 2007 | 131 | 0.020 |
Why?
|
Allosteric Site | 1 | 2007 | 103 | 0.020 |
Why?
|
Autoimmune Diseases | 2 | 1996 | 2250 | 0.020 |
Why?
|
MART-1 Antigen | 1 | 2007 | 65 | 0.020 |
Why?
|
Metallothionein | 1 | 1987 | 61 | 0.020 |
Why?
|
Hematopoietic System | 1 | 2007 | 109 | 0.020 |
Why?
|
Blood Platelets | 1 | 1998 | 2520 | 0.020 |
Why?
|
Computational Biology | 1 | 1999 | 3505 | 0.020 |
Why?
|
Mitogen-Activated Protein Kinases | 2 | 2003 | 1246 | 0.020 |
Why?
|
Histocytochemistry | 1 | 1988 | 700 | 0.020 |
Why?
|
Cell Adhesion Molecules | 1 | 1993 | 1602 | 0.020 |
Why?
|
Glucosidases | 1 | 1986 | 12 | 0.020 |
Why?
|
Doxorubicin | 2 | 2011 | 2209 | 0.020 |
Why?
|
Retinoblastoma Protein | 1 | 1990 | 670 | 0.020 |
Why?
|
Carcinoma, Lewis Lung | 1 | 2007 | 107 | 0.020 |
Why?
|
Cell Cycle Proteins | 1 | 1998 | 3446 | 0.020 |
Why?
|
Tunicamycin | 1 | 2006 | 108 | 0.020 |
Why?
|
Insulin | 1 | 2001 | 6597 | 0.020 |
Why?
|
Memory | 1 | 1996 | 2179 | 0.020 |
Why?
|
Tryptophan | 1 | 1988 | 479 | 0.020 |
Why?
|
Sarcoma Viruses, Murine | 1 | 1986 | 17 | 0.020 |
Why?
|
Transplantation Conditioning | 1 | 2013 | 1588 | 0.020 |
Why?
|
Cottontail rabbit papillomavirus | 1 | 1986 | 2 | 0.020 |
Why?
|
Ion Channels | 1 | 1991 | 1043 | 0.020 |
Why?
|
Gene Expression Profiling | 1 | 2002 | 9411 | 0.020 |
Why?
|
Injections, Intradermal | 1 | 2006 | 116 | 0.020 |
Why?
|
HLA-DQ Antigens | 1 | 1987 | 211 | 0.020 |
Why?
|
Time Factors | 6 | 2006 | 40165 | 0.020 |
Why?
|
Longevity | 1 | 1994 | 1050 | 0.020 |
Why?
|
Salmonella typhimurium | 1 | 1988 | 344 | 0.020 |
Why?
|
Incidence | 1 | 2005 | 21392 | 0.020 |
Why?
|
Interleukin-15 | 1 | 2007 | 183 | 0.020 |
Why?
|
Antigen-Antibody Reactions | 1 | 2006 | 346 | 0.020 |
Why?
|
Immunoglobulin Heavy Chains | 1 | 1989 | 649 | 0.020 |
Why?
|
Protein Precursors | 2 | 1984 | 1134 | 0.020 |
Why?
|
Diagnosis, Differential | 1 | 2001 | 12965 | 0.020 |
Why?
|
Multiple Myeloma | 1 | 2004 | 5130 | 0.020 |
Why?
|
Allosteric Regulation | 1 | 2007 | 426 | 0.020 |
Why?
|
Half-Life | 1 | 2007 | 652 | 0.020 |
Why?
|
Safety | 1 | 2010 | 1148 | 0.020 |
Why?
|
Epidermal Growth Factor | 1 | 1988 | 695 | 0.020 |
Why?
|
Mice, Inbred NOD | 2 | 2001 | 1837 | 0.020 |
Why?
|
Antigens, Viral, Tumor | 1 | 1986 | 153 | 0.020 |
Why?
|
Binding Sites | 2 | 1994 | 6048 | 0.020 |
Why?
|
Telomerase | 1 | 2011 | 746 | 0.020 |
Why?
|
Drug Resistance, Microbial | 1 | 1989 | 856 | 0.020 |
Why?
|
Pericytes | 1 | 2008 | 293 | 0.020 |
Why?
|
Hyperlipidemias | 1 | 1990 | 782 | 0.020 |
Why?
|
DNA, Mitochondrial | 1 | 2011 | 858 | 0.020 |
Why?
|
RNA, Neoplasm | 1 | 2008 | 749 | 0.020 |
Why?
|
Cystic Fibrosis | 2 | 1991 | 1274 | 0.020 |
Why?
|
Polycythemia | 1 | 2006 | 125 | 0.020 |
Why?
|
Thrombospondin 1 | 1 | 2007 | 257 | 0.020 |
Why?
|
Cytotoxicity, Immunologic | 1 | 2009 | 1351 | 0.020 |
Why?
|
Intermediate Filament Proteins | 1 | 2006 | 263 | 0.020 |
Why?
|
Polyomavirus | 1 | 1986 | 234 | 0.020 |
Why?
|
Chemokine CXCL12 | 1 | 2007 | 454 | 0.020 |
Why?
|
Myositis | 1 | 2008 | 269 | 0.020 |
Why?
|
Hybridomas | 2 | 2002 | 442 | 0.020 |
Why?
|
Myoblasts, Skeletal | 1 | 2005 | 75 | 0.020 |
Why?
|
C-Reactive Protein | 1 | 1997 | 3839 | 0.020 |
Why?
|
Syndecan-4 | 2 | 1994 | 44 | 0.020 |
Why?
|
Blotting, Northern | 2 | 2001 | 1543 | 0.020 |
Why?
|
T-Lymphocyte Subsets | 1 | 1993 | 1810 | 0.020 |
Why?
|
CD4-CD8 Ratio | 1 | 2004 | 114 | 0.020 |
Why?
|
H-2 Antigens | 1 | 1985 | 358 | 0.020 |
Why?
|
Integrases | 1 | 2007 | 516 | 0.020 |
Why?
|
Carotid Arteries | 1 | 1989 | 951 | 0.010 |
Why?
|
Vascular Endothelial Growth Factor D | 1 | 2004 | 64 | 0.010 |
Why?
|
Patient Selection | 1 | 1997 | 4283 | 0.010 |
Why?
|
Prostate-Specific Antigen | 2 | 2006 | 2529 | 0.010 |
Why?
|
Liver Diseases | 1 | 1993 | 1302 | 0.010 |
Why?
|
Cyclophilin A | 1 | 2004 | 58 | 0.010 |
Why?
|
Heterozygote | 1 | 1991 | 2798 | 0.010 |
Why?
|
Oncogene Proteins, Viral | 1 | 1986 | 341 | 0.010 |
Why?
|
Antibodies, Monoclonal | 3 | 2002 | 9185 | 0.010 |
Why?
|
Carcinoma, Non-Small-Cell Lung | 1 | 2003 | 5251 | 0.010 |
Why?
|
Swine | 3 | 2002 | 5899 | 0.010 |
Why?
|
CD4-Positive T-Lymphocytes | 1 | 1997 | 4353 | 0.010 |
Why?
|
Neoplasm Transplantation | 1 | 2008 | 2014 | 0.010 |
Why?
|
Proto-Oncogene Proteins c-hck | 1 | 2004 | 46 | 0.010 |
Why?
|
Selection, Genetic | 3 | 1988 | 869 | 0.010 |
Why?
|
Microscopy, Fluorescence | 2 | 2001 | 2651 | 0.010 |
Why?
|
Motivation | 1 | 2014 | 1993 | 0.010 |
Why?
|
Vascular Endothelial Growth Factor C | 1 | 2004 | 127 | 0.010 |
Why?
|
NG-Nitroarginine Methyl Ester | 1 | 2004 | 260 | 0.010 |
Why?
|
Psychomotor Performance | 1 | 2012 | 1878 | 0.010 |
Why?
|
Homeodomain Proteins | 1 | 1993 | 2414 | 0.010 |
Why?
|
History, 20th Century | 1 | 1992 | 2773 | 0.010 |
Why?
|
Hippocampus | 1 | 1996 | 3738 | 0.010 |
Why?
|
Teratoma | 1 | 1986 | 403 | 0.010 |
Why?
|
Radiation Tolerance | 1 | 2006 | 480 | 0.010 |
Why?
|
beta-N-Acetylhexosaminidases | 1 | 2003 | 43 | 0.010 |
Why?
|
Polymorphism, Genetic | 1 | 2014 | 4291 | 0.010 |
Why?
|
Protein Kinases | 2 | 1991 | 1612 | 0.010 |
Why?
|
Oncogenes | 1 | 1989 | 1220 | 0.010 |
Why?
|
Genomics | 1 | 1999 | 5794 | 0.010 |
Why?
|
Microscopy, Immunoelectron | 1 | 2003 | 317 | 0.010 |
Why?
|
Structure-Activity Relationship | 2 | 2003 | 3084 | 0.010 |
Why?
|
Physicians | 1 | 2001 | 4591 | 0.010 |
Why?
|
Haplorhini | 2 | 1981 | 529 | 0.010 |
Why?
|
Bone and Bones | 1 | 1994 | 2560 | 0.010 |
Why?
|
Lupus Erythematosus, Systemic | 1 | 1996 | 2159 | 0.010 |
Why?
|
Phosphotyrosine | 1 | 2004 | 456 | 0.010 |
Why?
|
Gamma Rays | 1 | 2004 | 317 | 0.010 |
Why?
|
Acoustic Stimulation | 1 | 2007 | 1232 | 0.010 |
Why?
|
L-Selectin | 1 | 2003 | 209 | 0.010 |
Why?
|
Reactive Oxygen Species | 1 | 2011 | 2138 | 0.010 |
Why?
|
Lung Diseases | 1 | 1993 | 1915 | 0.010 |
Why?
|
Phospholipase C gamma | 1 | 2003 | 130 | 0.010 |
Why?
|
Disease-Free Survival | 1 | 2013 | 6828 | 0.010 |
Why?
|
Caffeine | 1 | 2007 | 702 | 0.010 |
Why?
|
Type C Phospholipases | 1 | 2003 | 287 | 0.010 |
Why?
|
Skin Tests | 1 | 2004 | 637 | 0.010 |
Why?
|
Receptors, CXCR4 | 1 | 2007 | 728 | 0.010 |
Why?
|
Affect | 1 | 2010 | 1480 | 0.010 |
Why?
|
Hypoxia-Inducible Factor 1, alpha Subunit | 1 | 2006 | 621 | 0.010 |
Why?
|
Organ Size | 1 | 2007 | 2254 | 0.010 |
Why?
|
Tyrosine | 1 | 2006 | 1438 | 0.010 |
Why?
|
Cell Degranulation | 1 | 2003 | 276 | 0.010 |
Why?
|
Mammary Tumor Virus, Mouse | 1 | 1981 | 41 | 0.010 |
Why?
|
Expressed Sequence Tags | 1 | 2002 | 250 | 0.010 |
Why?
|
Listeria | 1 | 2001 | 25 | 0.010 |
Why?
|
Wiskott-Aldrich Syndrome Protein | 1 | 2002 | 160 | 0.010 |
Why?
|
Defective Viruses | 2 | 1997 | 89 | 0.010 |
Why?
|
Wounds and Injuries | 1 | 1994 | 2477 | 0.010 |
Why?
|
Wiskott-Aldrich Syndrome Protein, Neuronal | 1 | 2001 | 86 | 0.010 |
Why?
|
Glucose Transporter Type 2 | 1 | 2001 | 61 | 0.010 |
Why?
|
Syndrome | 1 | 2008 | 3280 | 0.010 |
Why?
|
District of Columbia | 1 | 2001 | 160 | 0.010 |
Why?
|
Prognosis | 1 | 2002 | 29658 | 0.010 |
Why?
|
Lateral Ventricles | 1 | 2002 | 146 | 0.010 |
Why?
|
Collagen Type XVIII | 1 | 2001 | 52 | 0.010 |
Why?
|
Hematopoietic Stem Cell Mobilization | 1 | 2002 | 225 | 0.010 |
Why?
|
Epithelium | 2 | 1996 | 1605 | 0.010 |
Why?
|
Leukoplakia, Oral | 1 | 2001 | 77 | 0.010 |
Why?
|
E-Selectin | 1 | 2003 | 576 | 0.010 |
Why?
|
Reaction Time | 1 | 2007 | 2075 | 0.010 |
Why?
|
Chicago | 1 | 2001 | 244 | 0.010 |
Why?
|
Leukoplakia, Hairy | 1 | 2000 | 9 | 0.010 |
Why?
|
Rats, Sprague-Dawley | 2 | 2004 | 8158 | 0.010 |
Why?
|
Antigens, CD7 | 1 | 2000 | 30 | 0.010 |
Why?
|
Transcription Factors | 2 | 2011 | 12103 | 0.010 |
Why?
|
Secretory Rate | 1 | 2000 | 81 | 0.010 |
Why?
|
Neoplastic Stem Cells | 1 | 1989 | 1347 | 0.010 |
Why?
|
Receptors, Antigen, T-Cell, alpha-beta | 1 | 2004 | 801 | 0.010 |
Why?
|
Morphogenesis | 2 | 2001 | 740 | 0.010 |
Why?
|
Excipients | 1 | 2001 | 97 | 0.010 |
Why?
|
Chromosomes | 1 | 1984 | 575 | 0.010 |
Why?
|
Shigella flexneri | 1 | 2001 | 119 | 0.010 |
Why?
|
Amino Acid Motifs | 1 | 2003 | 929 | 0.010 |
Why?
|
rac GTP-Binding Proteins | 1 | 2001 | 162 | 0.010 |
Why?
|
Neoplasm Staging | 2 | 2006 | 11152 | 0.010 |
Why?
|
Lymphocyte Count | 1 | 2002 | 780 | 0.010 |
Why?
|
Submandibular Gland | 1 | 2000 | 87 | 0.010 |
Why?
|
Retinal Vessels | 1 | 2006 | 836 | 0.010 |
Why?
|
Cisplatin | 1 | 2006 | 1644 | 0.010 |
Why?
|
Cytotoxins | 1 | 2001 | 153 | 0.010 |
Why?
|
Hyperplasia | 1 | 2003 | 1155 | 0.010 |
Why?
|
cdc42 GTP-Binding Protein | 1 | 2001 | 187 | 0.010 |
Why?
|
Chloride Channels | 2 | 1991 | 221 | 0.010 |
Why?
|
Dentists | 1 | 2001 | 176 | 0.010 |
Why?
|
Chromosome Deletion | 2 | 1983 | 1387 | 0.010 |
Why?
|
Vaccinia virus | 1 | 2001 | 331 | 0.010 |
Why?
|
Amino Acid Substitution | 1 | 2004 | 1737 | 0.010 |
Why?
|
Oral Ulcer | 1 | 2000 | 96 | 0.010 |
Why?
|
Angioplasty, Balloon | 1 | 2003 | 597 | 0.010 |
Why?
|
HIV Seronegativity | 1 | 2000 | 208 | 0.010 |
Why?
|
Minor Histocompatibility Antigens | 1 | 2000 | 293 | 0.010 |
Why?
|
Skin Neoplasms | 1 | 1999 | 5799 | 0.010 |
Why?
|
Dose-Response Relationship, Immunologic | 1 | 2000 | 365 | 0.010 |
Why?
|
rho GTP-Binding Proteins | 1 | 2001 | 277 | 0.010 |
Why?
|
Liver Neoplasms | 1 | 1995 | 4319 | 0.010 |
Why?
|
Nucleic Acid Precursors | 1 | 1979 | 15 | 0.010 |
Why?
|
Sequence Analysis, RNA | 1 | 2007 | 2005 | 0.010 |
Why?
|
Parotid Gland | 1 | 2000 | 175 | 0.010 |
Why?
|
Dimerization | 1 | 2001 | 891 | 0.010 |
Why?
|
ATP-Binding Cassette Transporters | 1 | 2002 | 563 | 0.010 |
Why?
|
New York City | 1 | 2001 | 724 | 0.010 |
Why?
|
Bioprosthesis | 1 | 2003 | 600 | 0.010 |
Why?
|
Up-Regulation | 1 | 2008 | 4122 | 0.010 |
Why?
|
Platelet-Derived Growth Factor | 1 | 2001 | 617 | 0.010 |
Why?
|
Diffusion | 1 | 2001 | 813 | 0.010 |
Why?
|
Cardiomyopathies | 1 | 2011 | 1952 | 0.010 |
Why?
|
Salivary Glands | 1 | 2000 | 229 | 0.010 |
Why?
|
Receptors, Fc | 1 | 2002 | 534 | 0.010 |
Why?
|
Liver Transplantation | 1 | 1990 | 2325 | 0.010 |
Why?
|
RNA, Small Interfering | 1 | 2008 | 3442 | 0.010 |
Why?
|
Down-Regulation | 1 | 2006 | 2913 | 0.010 |
Why?
|
Lung | 2 | 1996 | 9994 | 0.010 |
Why?
|
Anticoagulants | 1 | 1994 | 4897 | 0.010 |
Why?
|
bcl-X Protein | 1 | 2000 | 413 | 0.010 |
Why?
|
S100 Proteins | 1 | 1999 | 218 | 0.010 |
Why?
|
Methods | 1 | 1979 | 1074 | 0.010 |
Why?
|
Odds Ratio | 2 | 2001 | 9716 | 0.010 |
Why?
|
RNA Interference | 1 | 2007 | 2846 | 0.010 |
Why?
|
Interferon-gamma | 1 | 2007 | 3157 | 0.010 |
Why?
|
Cystic Fibrosis Transmembrane Conductance Regulator | 2 | 1991 | 446 | 0.010 |
Why?
|
Fanconi Anemia Complementation Group Proteins | 1 | 1998 | 97 | 0.010 |
Why?
|
Japan | 1 | 2002 | 1369 | 0.010 |
Why?
|
Immune Sera | 1 | 1998 | 613 | 0.010 |
Why?
|
Myocardium | 1 | 2011 | 4700 | 0.010 |
Why?
|
Sequence Homology, Amino Acid | 1 | 2002 | 2753 | 0.010 |
Why?
|
Sequence Alignment | 1 | 2002 | 2176 | 0.010 |
Why?
|
Fatal Outcome | 1 | 2002 | 1832 | 0.010 |
Why?
|
Dermatitis, Contact | 1 | 1998 | 133 | 0.010 |
Why?
|
Mitomycin | 1 | 1998 | 262 | 0.010 |
Why?
|
California | 1 | 2001 | 1416 | 0.010 |
Why?
|
Immunoglobulin Fc Fragments | 1 | 1999 | 280 | 0.010 |
Why?
|
Receptors, Cytokine | 1 | 1998 | 258 | 0.010 |
Why?
|
DNA Helicases | 1 | 2002 | 854 | 0.010 |
Why?
|
Smoking | 1 | 2014 | 9073 | 0.010 |
Why?
|
Infection Control | 1 | 2004 | 983 | 0.010 |
Why?
|
Capillaries | 1 | 2000 | 744 | 0.010 |
Why?
|
Receptors, Thrombopoietin | 1 | 1998 | 161 | 0.010 |
Why?
|
Pulmonary Surfactant-Associated Proteins | 1 | 1996 | 17 | 0.010 |
Why?
|
Cornea | 1 | 2004 | 1326 | 0.010 |
Why?
|
Microscopy, Electron | 1 | 2000 | 2558 | 0.010 |
Why?
|
Particle Size | 1 | 2001 | 1644 | 0.010 |
Why?
|
Pulmonary Surfactant-Associated Protein A | 1 | 1996 | 31 | 0.010 |
Why?
|
DNA Repair | 1 | 2006 | 2039 | 0.010 |
Why?
|
1,2-Dipalmitoylphosphatidylcholine | 1 | 1996 | 41 | 0.010 |
Why?
|
Protein Isoforms | 1 | 2001 | 1697 | 0.010 |
Why?
|
Mice, Inbred MRL lpr | 1 | 1996 | 153 | 0.010 |
Why?
|
Peer Review, Research | 1 | 1999 | 340 | 0.010 |
Why?
|
Gonadotropins, Equine | 1 | 1995 | 7 | 0.010 |
Why?
|
Receptors, Urokinase Plasminogen Activator | 1 | 1996 | 75 | 0.010 |
Why?
|
Lysophosphatidylcholines | 1 | 1996 | 77 | 0.010 |
Why?
|
RNA Probes | 1 | 1995 | 111 | 0.010 |
Why?
|
Logistic Models | 2 | 2001 | 13314 | 0.010 |
Why?
|
Palmitates | 1 | 1996 | 70 | 0.010 |
Why?
|
Codon, Initiator | 1 | 1996 | 51 | 0.010 |
Why?
|
DNA Damage | 1 | 2006 | 2442 | 0.010 |
Why?
|
Fibrinolysin | 1 | 1996 | 131 | 0.010 |
Why?
|
Culture Techniques | 1 | 1996 | 530 | 0.010 |
Why?
|
Saliva | 1 | 2000 | 820 | 0.010 |
Why?
|
Protein Binding | 1 | 2008 | 9335 | 0.010 |
Why?
|
Peptide Biosynthesis | 1 | 1975 | 52 | 0.010 |
Why?
|
Caseins | 1 | 1995 | 103 | 0.010 |
Why?
|
Antifungal Agents | 1 | 2000 | 749 | 0.010 |
Why?
|
Bacterial Toxins | 1 | 2001 | 931 | 0.010 |
Why?
|
Macrophages, Peritoneal | 1 | 1996 | 237 | 0.010 |
Why?
|
Th2 Cells | 1 | 2000 | 1047 | 0.010 |
Why?
|
HIV Seropositivity | 1 | 2000 | 955 | 0.010 |
Why?
|
Ubiquitin-Protein Ligases | 1 | 2004 | 1889 | 0.010 |
Why?
|
Receptor, Parathyroid Hormone, Type 1 | 1 | 1996 | 305 | 0.010 |
Why?
|
DNA Probes | 1 | 1995 | 551 | 0.010 |
Why?
|
Avoidance Learning | 1 | 1996 | 248 | 0.010 |
Why?
|
Statistics, Nonparametric | 1 | 2000 | 2852 | 0.010 |
Why?
|
Phosphatidylcholines | 1 | 1996 | 406 | 0.010 |
Why?
|
Neomycin | 2 | 1984 | 93 | 0.010 |
Why?
|
Follow-Up Studies | 2 | 2012 | 39261 | 0.010 |
Why?
|
Chondroitin Sulfates | 1 | 1994 | 174 | 0.010 |
Why?
|
Congresses as Topic | 1 | 1999 | 805 | 0.010 |
Why?
|
Carbohydrate Sequence | 1 | 1994 | 410 | 0.010 |
Why?
|
Choline | 1 | 1996 | 513 | 0.010 |
Why?
|
United States | 1 | 2002 | 72461 | 0.010 |
Why?
|
Chromatin | 1 | 2006 | 2938 | 0.010 |
Why?
|
Oligonucleotide Array Sequence Analysis | 1 | 2002 | 3775 | 0.010 |
Why?
|
Virus Integration | 1 | 1996 | 302 | 0.010 |
Why?
|
Chi-Square Distribution | 1 | 2000 | 3465 | 0.010 |
Why?
|
Drug Eruptions | 1 | 1997 | 335 | 0.010 |
Why?
|
Cell Count | 1 | 1998 | 1835 | 0.010 |
Why?
|
Recurrence | 1 | 2006 | 8482 | 0.010 |
Why?
|
Eosinophils | 1 | 1998 | 944 | 0.010 |
Why?
|
Prospective Studies | 2 | 2013 | 54303 | 0.010 |
Why?
|
Erythrocyte Count | 1 | 1993 | 157 | 0.010 |
Why?
|
Cecum | 1 | 1993 | 232 | 0.010 |
Why?
|
Space Perception | 1 | 1996 | 464 | 0.010 |
Why?
|
Feedback | 1 | 1996 | 791 | 0.010 |
Why?
|
Parathyroid Glands | 1 | 1974 | 517 | 0.010 |
Why?
|
Regional Blood Flow | 1 | 1996 | 1490 | 0.010 |
Why?
|
Superoxides | 1 | 1993 | 387 | 0.010 |
Why?
|
Transplantation, Isogeneic | 1 | 1992 | 248 | 0.010 |
Why?
|
Immunoglobulin Variable Region | 1 | 1993 | 419 | 0.010 |
Why?
|
Glucocorticoids | 1 | 1981 | 2145 | 0.010 |
Why?
|
Stromal Cells | 1 | 1997 | 1326 | 0.010 |
Why?
|
Clinical Trials as Topic | 1 | 2008 | 8056 | 0.010 |
Why?
|
Immunity | 1 | 1998 | 998 | 0.010 |
Why?
|
Survival Rate | 1 | 2006 | 12808 | 0.010 |
Why?
|
Acquired Immunodeficiency Syndrome | 1 | 2000 | 2197 | 0.010 |
Why?
|
Hedgehog Proteins | 1 | 1996 | 769 | 0.010 |
Why?
|
Neutrophils | 1 | 2004 | 3767 | 0.010 |
Why?
|
Skin Physiological Phenomena | 1 | 1992 | 188 | 0.010 |
Why?
|
Endotoxins | 1 | 1993 | 521 | 0.010 |
Why?
|
Radiography | 1 | 2002 | 6965 | 0.010 |
Why?
|
Viral Load | 1 | 2000 | 3322 | 0.010 |
Why?
|
Rats, Inbred F344 | 1 | 1992 | 825 | 0.010 |
Why?
|
Platelet Count | 1 | 1993 | 777 | 0.010 |
Why?
|
Rats, Inbred Strains | 1 | 1992 | 2094 | 0.010 |
Why?
|
Osteoblasts | 1 | 1996 | 1142 | 0.010 |
Why?
|
Regression Analysis | 1 | 2000 | 6360 | 0.010 |
Why?
|
Age Factors | 1 | 2007 | 18416 | 0.010 |
Why?
|
Electric Conductivity | 1 | 1991 | 410 | 0.010 |
Why?
|
Oligonucleotide Probes | 1 | 1990 | 418 | 0.010 |
Why?
|
Clinical Protocols | 1 | 1996 | 1440 | 0.010 |
Why?
|
Trachea | 1 | 1996 | 1082 | 0.010 |
Why?
|
Parathyroidectomy | 1 | 1992 | 241 | 0.010 |
Why?
|
Open Reading Frames | 1 | 1993 | 814 | 0.010 |
Why?
|
Cell Cycle | 1 | 1998 | 2934 | 0.010 |
Why?
|
Calcium | 1 | 2003 | 5725 | 0.010 |
Why?
|
Gonadotropin-Releasing Hormone | 1 | 1995 | 1153 | 0.010 |
Why?
|
Embryonal Carcinoma Stem Cells | 1 | 1989 | 20 | 0.010 |
Why?
|
RNA, Antisense | 1 | 1989 | 136 | 0.010 |
Why?
|
Bucladesine | 1 | 1989 | 118 | 0.010 |
Why?
|
Behavior, Animal | 1 | 1996 | 1866 | 0.000 |
Why?
|
Remission Induction | 1 | 1994 | 2392 | 0.000 |
Why?
|
Membrane Potentials | 1 | 1991 | 1095 | 0.000 |
Why?
|
Epitopes | 1 | 1994 | 2503 | 0.000 |
Why?
|
Neuronal Plasticity | 1 | 1996 | 1430 | 0.000 |
Why?
|
Herpesvirus 4, Human | 1 | 1993 | 1075 | 0.000 |
Why?
|
Keratins | 1 | 1989 | 497 | 0.000 |
Why?
|
Hemoglobins | 1 | 1993 | 1521 | 0.000 |
Why?
|
HLA-DP Antigens | 1 | 1987 | 28 | 0.000 |
Why?
|
Internet | 1 | 1999 | 3078 | 0.000 |
Why?
|
Cyclic AMP | 1 | 1991 | 1456 | 0.000 |
Why?
|
Biopsy | 1 | 1999 | 6771 | 0.000 |
Why?
|
Colchicine | 1 | 1988 | 261 | 0.000 |
Why?
|
Vinblastine | 1 | 1988 | 487 | 0.000 |
Why?
|
Thyroidectomy | 1 | 1992 | 902 | 0.000 |
Why?
|
Disease Progression | 1 | 2003 | 13502 | 0.000 |
Why?
|
Sarcoma, Experimental | 1 | 1986 | 117 | 0.000 |
Why?
|
Embolization, Therapeutic | 1 | 1996 | 1413 | 0.000 |
Why?
|
Immunoblotting | 1 | 1989 | 1649 | 0.000 |
Why?
|
Tretinoin | 1 | 1989 | 519 | 0.000 |
Why?
|
Neural Pathways | 1 | 1996 | 3040 | 0.000 |
Why?
|
Antigens, Polyomavirus Transforming | 1 | 1986 | 257 | 0.000 |
Why?
|
Moloney murine sarcoma virus | 1 | 1984 | 4 | 0.000 |
Why?
|
Feasibility Studies | 1 | 1996 | 5201 | 0.000 |
Why?
|
Genes, Synthetic | 1 | 1985 | 88 | 0.000 |
Why?
|
Isoenzymes | 1 | 1989 | 1690 | 0.000 |
Why?
|
Chimera | 1 | 1986 | 453 | 0.000 |
Why?
|
Risk Assessment | 1 | 2006 | 24123 | 0.000 |
Why?
|
Anti-HIV Agents | 1 | 2000 | 4491 | 0.000 |
Why?
|
Cell-Free System | 2 | 1975 | 341 | 0.000 |
Why?
|
Crosses, Genetic | 1 | 1985 | 751 | 0.000 |
Why?
|
Virus Activation | 1 | 1986 | 319 | 0.000 |
Why?
|
Cross Reactions | 1 | 1986 | 818 | 0.000 |
Why?
|
Skin | 1 | 1998 | 4466 | 0.000 |
Why?
|
HIV-1 | 1 | 2001 | 6849 | 0.000 |
Why?
|
Metaphase | 1 | 1984 | 144 | 0.000 |
Why?
|
Azacitidine | 1 | 1985 | 334 | 0.000 |
Why?
|
Databases, Factual | 1 | 1999 | 8035 | 0.000 |
Why?
|
Double-Blind Method | 1 | 1997 | 12427 | 0.000 |
Why?
|
DNA Mutational Analysis | 1 | 1991 | 4107 | 0.000 |
Why?
|
Ultrasonography | 1 | 1996 | 5961 | 0.000 |
Why?
|
Cholesterol | 1 | 1990 | 2924 | 0.000 |
Why?
|
Receptors, Immunologic | 1 | 1987 | 1411 | 0.000 |
Why?
|
Pulmonary Embolism | 1 | 1993 | 2543 | 0.000 |
Why?
|
Genetic Linkage | 1 | 1984 | 2381 | 0.000 |
Why?
|
CHO Cells | 1 | 1981 | 1389 | 0.000 |
Why?
|
Repressor Proteins | 1 | 1989 | 2981 | 0.000 |
Why?
|
Pituitary Neoplasms | 1 | 1984 | 1313 | 0.000 |
Why?
|
Gestational Age | 1 | 1984 | 3565 | 0.000 |
Why?
|
Algorithms | 1 | 1996 | 13981 | 0.000 |
Why?
|
Goats | 1 | 1975 | 167 | 0.000 |
Why?
|
Triticum | 1 | 1975 | 89 | 0.000 |
Why?
|
Chromatography, Paper | 1 | 1974 | 76 | 0.000 |
Why?
|
Cyanogen Bromide | 1 | 1974 | 73 | 0.000 |
Why?
|
Bacillus | 1 | 1975 | 78 | 0.000 |
Why?
|
Chemical Precipitation | 1 | 1974 | 176 | 0.000 |
Why?
|
Haemophilus influenzae | 1 | 1975 | 180 | 0.000 |
Why?
|
Precipitin Tests | 1 | 1975 | 814 | 0.000 |
Why?
|
Tritium | 1 | 1974 | 707 | 0.000 |
Why?
|
Plants | 1 | 1975 | 317 | 0.000 |
Why?
|
Leucine | 1 | 1974 | 547 | 0.000 |
Why?
|
DNA-Directed RNA Polymerases | 1 | 1975 | 367 | 0.000 |
Why?
|
Electrophoresis, Polyacrylamide Gel | 1 | 1974 | 1744 | 0.000 |
Why?
|
Methionine | 1 | 1974 | 569 | 0.000 |
Why?
|
Potassium | 1 | 1975 | 1313 | 0.000 |
Why?
|
Lysine | 1 | 1974 | 1001 | 0.000 |
Why?
|
Cattle | 1 | 1974 | 3847 | 0.000 |
Why?
|